NMN vs NAD is a question about one step in the same chain: NMN is the building block your body turns into NAD, the molecule every cell uses to make energy. Nearly all the human research on raising NAD by mouth tested NMN or a close relative, nicotinamide riboside (NR), not NAD itself. Across 12 trials, NMN raised blood NAD, while most blood sugar and cholesterol results did not differ from the control groups (Zhang 2025).
Below you'll find what NAD is and why levels fall with age, how NMN becomes NAD, why absorption is the question for NAD supplements, the two side by side, what the human studies found and where results were small or missing, and who should check with a doctor first. If you have searched "NMN vs NAD supplement", this is the research behind the question; the choice stays yours.
What NAD Is and Why Levels Fall With Age
NAD (nicotinamide adenine dinucleotide, often written NAD+) is a helper molecule found in every cell. It carries electrons in the reactions that turn food into energy, and the enzymes that repair DNA and switch genes on and off use it up as they work (Clement 2019). Your body builds NAD from forms of vitamin B3 and recycles it constantly.
Levels fall as we age. In blood samples from healthy people aged 20 to 87, plasma NAD+ fell significantly with age, while NADH, its reduced form, and some of its breakdown products rose (Clement 2019). That fall is the reason "NAD boosters" became a supplement category. Our NAD+ page lists the studies and products.
What NMN Is and How It Becomes NAD
NMN (nicotinamide mononucleotide) is the last building block before NAD: the body adds one piece to NMN and the result is NAD. NR sits one step earlier and is turned into NMN on the way. Together they are the NAD precursors most studied in people.
In the one trial we found that compared them directly, 65 healthy adults took NR, NMN or nicotinamide (a plain form of vitamin B3) for 14 days. NR and NMN raised blood NAD by similar amounts, and nicotinamide gave no lasting rise (Christen 2026). The same team found that gut bacteria turn NR and NMN into nicotinic acid, another form of B3, which may be part of how they work.
In our label database, 196 on-market products list NMN. Of the 94 that contain NMN alone, 60 are capsules, 26 powders and 8 tablets, and the middle one holds 300 mg per serving, with most between 250 and 500 mg. In our grading, 16 human studies tested NMN, three of them pooled analyses of several trials. See the NMN page for its studies, the doses that worked and the products ranked.
NAD Supplements: What They Are and Why Absorption Is the Question
"NAD supplements" covers three things: NAD+ itself, NADH, and the NAD precursors, NMN and NR, that the body turns into NAD. Products sold as NAD itself are the smaller group. Our label database holds 57 on-market products that contain NAD or NADH alone, sold as capsules, tablets, liquids and lozenges. The middle one holds 30 mg per serving, and most hold between 10 and 500 mg. That middle serving is a tenth of the middle NMN serving.
The question with NAD itself is whether it reaches your cells. It is about twice the size of NMN, and the research on swallowing it is thin. Even given by IV it does not simply add up: in a pilot study, blood NAD did not rise for the first 2 hours of a 6-hour infusion, because the body cleared it as fast as it went in (Grant 2019). A 2026 review of 33 human studies found that NR and NMN taken by mouth consistently raised NAD markers in the blood and were well tolerated, and it found no outcome trial of NAD itself given by IV or injection for aging or wellness (Gallagher 2026).
NADH has a small trial record of its own. A 2024 review of 10 randomized trials with 489 people, testing NADH or NAD precursors, found them well tolerated, with scattered results such as less anxiety and a lower peak heart rate in a stress test; the trials were small, in groups ranging from older adults to people with long-lasting fatigue (Gindri 2024). For the whole category, see our NAD supplements guide.
NMN vs NAD: Side by Side
| NMN | NAD (NAD+ or NADH) | |
|---|---|---|
| What it is | The building block one step before NAD | The molecule cells use; NADH is its reduced form |
| How it works | Taken by mouth, it raised blood NAD in trial after trial | Must get past the gut, or be given by IV, where the body cleared it fast in a pilot study |
| Human evidence | 16 human studies in our grading, three of them pooled analyses; results on walking, blood sugar and energy were mixed | Two in our grading tested NAD or NADH itself; no outcome trial of IV or injected NAD for aging or wellness |
| Typical dose | 250 to 900 mg a day in most trials, up to 2,000 mg; labels: middle 300 mg per serving | No dose set by trials; labels: middle 30 mg per serving, most 10 to 500 mg |
| Safety in trials | No rise in side effects at 250 to 2,000 mg a day for up to 24 weeks | NADH well tolerated in small trials; little data on products sold as NAD+ |
| Cost per dose | Divide the price by the mg of NMN in the bottle | Same sum; NAD labels hold far less per serving, so compare mg, not capsules |
Not sure which fits your stack? Get a protocol that checks it for you.
What the Human Studies Found, Including Where Results Were Small or Missing
Blood NAD. This is the one result that repeats. In 80 healthy middle-aged adults taking 300, 600 or 900 mg of NMN a day for 60 days, blood NAD rose in every NMN group and most at 600 and 900 mg, with no safety issues (Yi 2023). Pooled trials agree: NMN raised blood NAD across 12 trials of 513 adults (Zhang 2025).
Walking and muscle. In the same 60-day trial, distance in a six-minute walk rose more than on placebo in all three NMN groups, and a blood-based estimate of biological age held steady while it rose on placebo (Yi 2023). In 60 older adults, 250 mg a day for 12 weeks did not change the main stepping test, though 4-metre walking time was shorter and sleep scores were better than on placebo (Morifuji 2024). Across 9 trials of 412 middle-aged and older adults, walking speed improved and a liver enzyme fell (Wang 2025), but a pooled analysis of older adults, average ages 61 to 83, found that NMN did not change muscle mass, grip strength or walking speed (Prokopidis 2025). The two analyses drew on different trials, which is why they differ.
Blood sugar and blood pressure. In a 10-week trial of postmenopausal women with raised blood sugar who carried extra weight, NMN made muscle respond better to insulin, while placebo did not (Yoshino 2021). Pooled, though, most blood sugar and cholesterol measures did not differ from control, and the authors warned that NMN's benefits may be overstated (Zhang 2025). Across 15 trials, NMN did not change body weight, fasting blood sugar, HbA1c, cholesterol or systolic blood pressure, and lowered diastolic pressure slightly (Yang 2026).
Energy and sleep. Across 27 studies of 1,599 adults, none of the NAD boosters tested (NR, NMN, NADH and nicotinamide) improved how tired people felt or their sleep quality, while NMN improved endurance at medium and high doses (Gao 2026). See the energy goal page.
What is missing. The longest of the 15 trials pooled in 2026 lasted 24 weeks, so there is no long-term data, and the aging results are lab measures such as a blood-based age estimate, not how people age. Our healthy aging goal page ranks the ingredients studied for it, and our longevity supplements guide shows where NAD boosters sit among them.
Who Should Check With a Doctor First (People on Meds)
Talk to your doctor or pharmacist before starting NMN, NR or NAD if you take meds, especially meds for blood sugar or blood pressure, since trials saw small changes in insulin response and diastolic pressure. Across 15 trials at 250 to 2,000 mg a day for up to 24 weeks, NMN did not raise side effects or liver enzymes (Yang 2026), and single doses of up to 500 mg did not change blood pressure or heart rate in 10 healthy men (Irie 2020). We found no trials in pregnancy or breastfeeding. Rala, the AI behind Reverse Age Lab, checks every product in your stack against your meds before it places anything in your protocol, and blood work is optional.
Is this medical advice? No. This guide sets out the published research on NMN and NAD; it is not a diagnosis, and Rala isn't a medical device or a clinician. Talk to your doctor before adding an NAD booster, especially if you take meds.
Bottom Line: Which One for Which Person
NMN and NAD aim at the same thing, more NAD in your cells, but the human evidence sits almost entirely with NMN and NR. For a person who wants the form with trials behind it, NMN taken by mouth raised blood NAD in trial after trial, at 250 to 900 mg a day in most of them; what that does for walking, blood sugar or energy is mixed and short-term. For a person looking at NAD or NADH products, they hold far less per serving, about 30 mg in the middle, and their trial record is a handful of small studies. NR, covered on our nicotinamide riboside page, raised blood NAD as much as NMN in the one direct comparison. Either way, the practical questions are which molecule the label names, how many mg each serving holds, what it costs per mg, and whether your meds call for a word with your doctor first.
Check Your NAD Booster Against Your Whole Stack
Your Daily Protocol adds up the NMN, NR, NAD and vitamin B3 in every product you take, including multivitamins and blends, checks them against your meds and places each one at the right time of day. Build My Protocol – 7-Day Free Trial.
Frequently Asked Questions
Is NMN better than NAD?
For raising NAD by mouth, the trials tested NMN and NR, not NAD itself. NMN raised blood NAD consistently; we found only small trials of NADH and no outcome trial of NAD given by IV or injection.
What is NMN?
Nicotinamide mononucleotide, the building block the body turns into NAD in one step. On-market NMN products in our label database hold 300 mg per serving in the middle.
What are NAD precursors?
Compounds the body turns into NAD: NMN, NR and the forms of vitamin B3, nicotinamide and nicotinic acid. In a 14-day trial, NR and NMN raised blood NAD by similar amounts and nicotinamide gave no lasting rise.
What dose of NMN did the trials use?
Most used 250 to 900 mg a day, and the 2026 pooled analysis covered 250 to 2,000 mg a day for up to 24 weeks. The NMN page shows the dose behind each result.
Do NAD IV drips work?
A 2026 review found no trial of IV or injected NAD itself on any aging or wellness outcome, and in a pilot study blood NAD did not rise for the first 2 hours of a 6-hour infusion.
Is NMN safe to take every day?
Across 15 trials at up to 2,000 mg a day for up to 24 weeks, NMN did not raise side effects or liver enzymes. Check with your doctor first if you take meds, especially for blood sugar or blood pressure.
Sources
Clement J, Wong M, Poljak A et al. The plasma NAD+ metabolome is dysregulated in "normal" aging. Rejuvenation Research, 2019. PubMed.
Christen S, Redeuil K, Goulet L et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nature Metabolism, 2026. PubMed.
Grant R, Berg J, Mestayer R et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD. Frontiers in Aging Neuroscience, 2019. PubMed.
Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: a PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Research Reviews, 2026. PubMed.
Gindri IM, Ferrari G, Pinto LPS et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. American Journal of Physiology: Endocrinology and Metabolism, 2024. PubMed.
Yi L, Maier AB, Tao R et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience, 2023. PubMed.
Morifuji M, Higashi S, Ebihara S et al. Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. GeroScience, 2024. PubMed.
Wang JP, Wang L, Wang T et al. Effects of nicotinamide mononucleotide supplementation on muscle and liver functions among the middle-aged and elderly: a systematic review and meta-analysis of randomized controlled trials. Current Pharmaceutical Biotechnology, 2025. PubMed.
Prokopidis K, Moriarty F, Bahat G et al. The effect of nicotinamide mononucleotide and riboside on skeletal muscle mass and function: a systematic review and meta-analysis. Journal of Cachexia, Sarcopenia and Muscle, 2025. PubMed.
Yoshino M, Yoshino J, Kayser BD et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in postmenopausal women with raised blood sugar (title paraphrased). Science, 2021. PubMed.
Zhang J, Poon ET, Wong SH. Efficacy of oral nicotinamide mononucleotide supplementation on glucose and lipid metabolism for adults: a systematic review with meta-analysis on randomized controlled trials. Critical Reviews in Food Science and Nutrition, 2025. PubMed.
Yang W, Huang J, Tang Z et al. Safety and metabolism-related outcomes of oral nicotinamide mononucleotide supplementation in adults: a systematic review and meta-analysis. Nutrients, 2026. PubMed.
Gao Y, Li S, Guan J et al. Domain-specific effects of NAD+ precursors on fatigue and functional performance: a systematic review and network meta-analysis. Frontiers in Nutrition, 2026. PubMed.
Irie J, Inagaki E, Fujita M et al. Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal, 2020. PubMed.
